CML Highlights: Has Molecular Monitoring Replaced Cytogenetic Monitoring? Is Imatinib Effective Initial Treatment in Chronic Phase? Are High-Risk ACA Associated With Reduced Survival?
Comments 0
Login to view comments.
Click here to Login
